Literature DB >> 16778099

Human in vivo dose-response to controlled, low-dose low linear energy transfer ionizing radiation exposure.

Zelanna Goldberg1, David M Rocke, Chad Schwietert, Susanne R Berglund, Alison Santana, Angela Jones, Jörg Lehmann, Robin Stern, Ruixiao Lu, Christine Hartmann Siantar.   

Abstract

PURPOSE: The effect of low doses of low-linear energy transfer (photon) ionizing radiation (LDIR, <10 cGy) on human tissue when exposure is under normal physiologic conditions is of significant interest to the medical and scientific community in therapeutic and other contexts. Although, to date, there has been no direct assessment of the response of human tissue to LDIR when exposure is under normal physiologic conditions of intact three-dimensional architecture, vasculature, and cell-cell contacts (between epithelial cells and between epithelial and stromal cells). EXPERIMENTAL
DESIGN: In this article, we present the first data on the response of human tissue exposed in vivo to LDIR with precisely controlled and calibrated doses. We evaluated transcriptomic responses to a single exposure of LDIR in the normal skin of men undergoing therapeutic radiation for prostate cancer (research protocol, Health Insurance Portability and Accountability Act-compliant, Institutional Review Board-approved). Using newly developed biostatistical tools that account for individual splice variants and the expected variability of temporal response between humans even when the outcome is measured at a single time, we show a dose-response pattern in gene expression in a number of pathways and gene groups that are biologically plausible responses to LDIR.
RESULTS: Examining genes and pathways identified as radiation-responsive in cell culture models, we found seven gene groups and five pathways that were altered in men in this experiment. These included the Akt/phosphoinositide-3-kinase pathway, the growth factor pathway, the stress/apoptosis pathway, and the pathway initiated by transforming growth factor-beta signaling, whereas gene groups with altered expression included the keratins, the zinc finger proteins and signaling molecules in the mitogen-activated protein kinase gene group. We show that there is considerable individual variability in radiation response that makes the detection of effects difficult, but still feasible when analyzed according to gene group and pathway.
CONCLUSIONS: These results show for the first time that low doses of radiation have an identifiable biosignature in human tissue, irradiated in vivo with normal intact three-dimensional architecture, vascular supply, and innervation. The genes and pathways show that the tissue (a) does detect the injury, (b) initiates a stress/inflammatory response, (c) undergoes DNA remodeling, as suggested by the significant increase in zinc finger protein gene expression, and (d) initiates a "pro-survival" response. The ability to detect a distinct radiation response pattern following LDIR exposure has important implications for risk assessment in both therapeutic and national defense contexts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778099     DOI: 10.1158/1078-0432.CCR-05-2625

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  23 in total

Review 1.  Functional genomics in radiation biology: a gateway to cellular systems-level studies.

Authors:  Sally A Amundson
Journal:  Radiat Environ Biophys       Date:  2007-11-01       Impact factor: 1.925

2.  Functional Genomics and a New Era in Radiation Biology and Oncology.

Authors:  Sally A Amundson
Journal:  Bioscience       Date:  2008-06-01       Impact factor: 8.589

3.  Global gene expression responses to low- or high-dose radiation in a human three-dimensional tissue model.

Authors:  Alexandre Mezentsev; Sally A Amundson
Journal:  Radiat Res       Date:  2011-04-12       Impact factor: 2.841

Review 4.  DNA damage-associated biomarkers in studying individual sensitivity to low-dose radiation from cardiovascular imaging.

Authors:  Won Hee Lee; Patricia K Nguyen; Dominik Fleischmann; Joseph C Wu
Journal:  Eur Heart J       Date:  2016-06-05       Impact factor: 29.983

5.  Prediction of in vivo radiation dose status in radiotherapy patients using ex vivo and in vivo gene expression signatures.

Authors:  Sunirmal Paul; Christopher A Barker; Helen C Turner; Amanda McLane; Suzanne L Wolden; Sally A Amundson
Journal:  Radiat Res       Date:  2011-01-10       Impact factor: 2.841

6.  Transcriptional response of ex vivo human skin to ionizing radiation: comparison between low- and high-dose effects.

Authors:  Huguette Albrecht; Blythe Durbin-Johnson; Reem Yunis; Karen M Kalanetra; Shiquan Wu; Rachel Chen; Thomas R Stevenson; David M Rocke
Journal:  Radiat Res       Date:  2011-10-26       Impact factor: 2.841

7.  Transient genome-wide transcriptional response to low-dose ionizing radiation in vivo in humans.

Authors:  Susanne R Berglund; David M Rocke; Jian Dai; Chad W Schwietert; Alison Santana; Robin L Stern; Joerg Lehmann; Christine L Hartmann Siantar; Zelanna Goldberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-08       Impact factor: 7.038

8.  Proteomic analysis of low dose arsenic and ionizing radiation exposure on keratinocytes.

Authors:  Susanne R Berglund; Alison R Santana; Dan Li; Robert H Rice; David M Rocke; Zelanna Goldberg
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

9.  Differential gene expression in primary human skin keratinocytes and fibroblasts in response to ionizing radiation.

Authors:  Raymond L Warters; Ann T Packard; Gwen F Kramer; David K Gaffney; Philip J Moos
Journal:  Radiat Res       Date:  2009-07       Impact factor: 2.841

10.  Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident.

Authors:  Michael Abend; Ruth M Pfeiffer; Christian Ruf; Maureen Hatch; Tetiana I Bogdanova; Mykola D Tronko; Armin Riecke; Julia Hartmann; Viktor Meineke; Houda Boukheris; Alice J Sigurdson; Kiyohiko Mabuchi; Alina V Brenner
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.